Why conventional therapy sometimes falls short
For many patients, artificial tears, anti-inflammatory drops, and punctal occlusion provide meaningful relief. But a subset of patients - those with significant corneal staining, filamentary keratitis, or persistent epithelial breakdown - need a therapy that actively supports healing of the ocular surface itself.
The biologic rationale
Amniotic membrane contains a stromal matrix rich in collagen, laminin, fibronectin, and growth-supporting factors. When placed on the ocular surface, it acts as a biologic bandage: protecting the cornea, reducing inflammation, and creating a scaffold that encourages epithelial migration.
Practical considerations for practice
Candidate selection typically focuses on patients with moderate to severe disease who have failed stepwise therapy.
In-office placement is performed under topical anesthesia and fits within a standard exam slot.
Follow-up within days confirms dissolution or retention and documents surface improvement with staining photography.
Looking ahead
As dry eye protocols mature, biologic therapies are increasingly positioned not as a last resort but as an earlier intervention for the right phenotype.
This article is provided for clinician education and does not constitute medical advice or a product-specific claim.